TRAUMA-INDUCED REPROGRAMMING: CHANGES IN LIPID RAFT PROTEIN CONTENT
TRAUMA-INDUCED REPROGRAMMING: CHANGES IN LIPID RAFT PROTEIN CONTENT
批准号:
7602876
负责人:
Joseph Cuschieri
金额:
$6.3万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2008-06-30
关键词:
Cell membraneCellsCentrifugationCeramidesCholesterolComplement 5aComplexComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentFocal AdhesionsFundingGrantHarvestHydrogen PeroxideIn VitroInfectionInjuryInstitutionInvadedLipopolysaccharidesMembrane FluidityMembrane MicrodomainsMononuclearNatural ImmunityOrgan failureOrganismOxidantsPatientsPhenotypePlatelet Activating FactorPredispositionProcessProductionProteinsRecruitment ActivityResearchResearch PersonnelResourcesSourceSphingolipidsStressSucroseSystemTimeToll-like receptorsTraumaUnited States National Institutes of HealthWorkbaseinjuredlipid mediatorprognosticresponsetherapeutic target
中文摘要
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
严重创伤后,单核细胞被重新编程,导致先天免疫的改变。 这些表型导致对入侵生物体的易感性增加,从而导致器官衰竭的发展。 这种状态已经在体外通过使单个核细胞经受创伤诱导的因子(包括血小板活化因子(PAF)、氧化应激和补体5a)来重建
(C5a)。 虽然负责这种重编程的机制仍然未知,但以前的工作已经证明,这一过程可能与特定质膜微区中蛋白质含量的改变有关,这些微区富含胆固醇和鞘脂,称为脂筏。 损伤后,我们假设创伤引起的因素导致脂质介体神经酰胺从脂筏的生产。 神经酰胺一旦产生就在筏内融合,导致大域的形成,从而导致膜流动性的变化。 由于这些变化,各种蛋白质被募集到脂筏,导致形成粘着斑样复合物,其含有一些但不是全部的Toll样受体(TLR)组分。 将遵循以下实验方法:分化的THP-1细胞将接受脂多糖(LPS)刺激不同时间段,最长60 min。选择的细胞将用PAF、过氧化氢或C5 a预处理30-60 min。将使用蔗糖梯度离心进行脂筏蛋白提取。 然后将收获的蛋白质用于使用LC-ESI-MS系统进行分析。 我们的假设是,这些复合物的组装和脂筏含量的变化是负责随后的重编程,诱导增强激活响应随后的感染。 基于这些体外观察,我们希望探索严重创伤患者发生的潜在变化,以确定潜在的预后和治疗靶点。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Following severe trauma mononuclear cells are reprogrammed leading to alterations in innate immunity. These phenotypes are responsible for increased susceptibility to invading organisms leading to the development of organ failure. This state has been recreated in vitro by subjecting mononuclear cells to factors induced by trauma, including platelet activating factor (PAF), oxidant stress and complement 5a
(C5a). Although the mechanism(s) responsible for this reprogramming remain unknown, previous work has demonstrated that this process may be associated with alterations in the protein content within specific plasma membrane microdomains that are rich in cholesterol and sphingolipids termed lipid rafts. Following injury, we hypothesize that factors induced by trauma result in the production of the lipid mediator ceramide from lipid rafts. Ceramide once produced fuses within rafts leading to the formation of macrodomains resulting in changes in membrane fluidity. Due to these changes, various proteins are recruited to the lipid raft resulting in the formation of focal adhesion-like complexes that contain some but not all of the Toll-like receptor (TLR) components. The following experimental approach will be followed: Differentiated THP-1 cells will be subjected to lipopolysaccharide (LPS) stimulation for various periods of time up to 60 min. Selected cells will be pre-treated with PAF, hydrogen peroxide or C5a for periods of time up to 30-60 min. Lipid raft protein extraction will be performed using sucrose gradient centrifugation. Harvested proteins will then be used for analysis using the LC-ESI-MS system. It is our hypothesis that assembly of these complexes and changes in lipid raft content are responsible for subsequent reprogramming that induces enhanced activation in response to subsequent infection. Based on these in vitro observations, it is our hope to then explore potential changes that occur in severely injured trauma patients in order to determine potential prognostic and therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENDOTOXIN EXPOSURE IN THE MACROPHAGE: ANALYSIS OF LIPID RAFT PROTEOMICS
-
批准号:7721400
-
项目类别:
-
资助金额:$2.4万
-
财政年份:2008
-
负责人:Joseph Cuschieri
-
依托单位:
TRAUMA & SEPSIS INDUCED CHANGES IN IMMUNE CELL MEMBRANE RECEPTOR TRAFFICKING
-
批准号:7294030
-
项目类别:
-
资助金额:$27.05万
-
财政年份:2007
-
负责人:Joseph Cuschieri
-
依托单位:
TRAUMA & SEPSIS INDUCED CHANGES IN IMMUNE CELL MEMBRANE RECEPTOR TRAFFICKING
-
批准号:8096537
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2007
-
负责人:Joseph Cuschieri
-
依托单位:
TRAUMA & SEPSIS INDUCED CHANGES IN IMMUNE CELL MEMBRANE RECEPTOR TRAFFICKING
-
批准号:7489990
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2007
-
负责人:Joseph Cuschieri
-
依托单位:
TRAUMA & SEPSIS INDUCED CHANGES IN IMMUNE CELL MEMBRANE RECEPTOR TRAFFICKING
-
批准号:7657322
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2007
-
负责人:Joseph Cuschieri
-
依托单位:
TRAUMA & SEPSIS INDUCED CHANGES IN IMMUNE CELL MEMBRANE RECEPTOR TRAFFICKING
-
批准号:7878793
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2007
-
负责人:Joseph Cuschieri
-
依托单位:
TRAUMA-INDUCED REPROGRAMMING: CHANGES IN LIPID RAFT PROTEIN CONTENT
-
批准号:7359117
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2006
-
负责人:Joseph Cuschieri
-
依托单位:
Cellular Signaling Mechanisms in Macrophage Activation.
-
批准号:7119242
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2003
-
负责人:Joseph Cuschieri
-
依托单位:
Cellular Signaling Mechanisms in Macrophage Activation.
-
批准号:6911417
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2003
-
负责人:Joseph Cuschieri
-
依托单位:
Cellular Signaling Mechanisms in Macrophage Activation.
-
批准号:6793748
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2003
-
负责人:Joseph Cuschieri
-
依托单位:
Cellular Signaling Mechanisms in Macrophage Activation.
-
批准号:7276148
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2003
-
负责人:Joseph Cuschieri
-
依托单位:
Cellular Signaling Mechanisms in Macrophage Activation.
-
批准号:6676830
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2003
-
负责人:Joseph Cuschieri
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
-
批准号:82470907
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2024
-
负责人:余学锋
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: